CSIMarket
 


Rockwell Medical inc   (RMTI)
Other Ticker:  
 

Cumulative Rockwell Medical Inc 's Quick Ratio for Trailing Twelve Months Period

RMTI's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

RMTI Quick Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Growth 10.7 % -5.84 % -23.09 % -15.62 % -11.11 %
Y / Y Cash & cash equivalent Growth -57.44 % -51.71 % 69.8 % -4.22 % -16.98 %
Quick Ratio for Trailing Twelve Months Period 0.91 1.16 1.37 1.19 1.16
Total Ranking # 1481 # 1408 # 1411 # 1813 # 1858
Seq. Current Liabilities Growth 22.67 % 15.81 % -14.82 % -8.52 % 4.33 %
Seq. Cash & cash equivalent Growth -21.09 % -11.7 % -21.67 % -22.03 % -10.45 %


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Due to growth in Current Liabilities in the III. Quarter to $21 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 0.91 below Rockwell Medical Inc average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 417 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Rockwell Medical Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about RMTI
Quick Ratio RMTI in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 418
Sector # 788
S&P 500 # 1893


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
4.9 2.5 0.91
(Dec 31 2017)   (Sep 30 2023)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Acadia Pharmaceuticals Inc   2.46 
Corbus Pharmaceuticals Holdings Inc   2.44 
Igc Pharma Inc   2.43 
Kiora Pharmaceuticals Inc  2.42 
Tempest Therapeutics Inc   2.41 
Cara Therapeutics inc   2.40 
Bullfrog Ai Holdings Inc   2.40 
Ironwood Pharmaceuticals inc   2.37 
Eton Pharmaceuticals Inc   2.36 
Ardelyx Inc   2.36 
Catalyst Biosciences Inc   2.34 
Mereo Biopharma Group Plc  2.34 
Bellerophon Therapeutics inc  2.32 
Cyclerion Therapeutics Inc   2.32 
Innoviva Inc   2.30 
Omeros Corp  2.29 
Gri Bio Inc   2.24 
Pacira Biosciences inc   2.23 
Cyclacel Pharmaceuticals Inc   2.17 
Fsd Pharma Inc   2.17 
Equillium Inc   2.13 
Purple Biotech Ltd   2.13 
Addex Therapeutics Ltd  2.12 
Sigilon Therapeutics Inc   2.11 
Longeveron Inc   2.01 
Macrogenics Inc   2.01 
Hutchmed china Limited  2.00 
2seventy Bio Inc   1.97 
Mersana Therapeutics Inc   1.94 
Biodexa Pharmaceuticals Plc  1.94 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com